BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tziomalos K. Combination treatment in HBeAg-negative chronic hepatitis B. World J Hepatol 2009; 1(1): 43-47 [PMID: 21160964 DOI: 10.4254/wjh.v1.i1.43]
URL: https://www.wjgnet.com/1007-9327/full/v1/i1/43.htm
Number Citing Articles
1
A. K. Vyas, A. Jindal, S. Hissar, G. Ramakrishna, N. Trehanpati. Immune balance in Hepatitis B Infection: Present and Future TherapiesScandinavian Journal of Immunology 2017; 86(1): 4 doi: 10.1111/sji.12553
2
Akinobu Tawada, Tatsuo Kanda, Fumio Imazeki, Osamu Yokosuka. Prevention of hepatitis B virus-associated liver diseases by antiviral therapyHepatology International 2016; 10(4): 574 doi: 10.1007/s12072-016-9720-y
3
Arezoo Estakhri, Ashraf Mohamadkhani, Hosein Poustchi, Ghodrat Montazeri. Impact of Lamivudine plus Adefovir therapy in chronic hepatitis B Iranian patients, resistant to Lamivudine treatment alone, on disease inhibition: A pilot studyOpen Journal of Gastroenterology 2012; 2(02): 72 doi: 10.4236/ojgas.2012.22015